Podcast

Podcast: GLP-1 drugs and the impact on food and beverages

12 December 2024 15:01 RaboResearch

Over the past 12 months, Ozempic and similar drugs have been hailed in the news as miracle solutions for rapid weight loss with minimal side effects. Weight loss often happens because of the changes in food and beverage consumption that these drugs trigger. In this episode of Consumer Foods to Go, Maria Castroviejo and Cyrille Filott discuss the impact of GLP-1 drugs on the food sector with podcast regular Nick Fereday. There is an impact, but much remains unknown.

Disclaimer

This document is meant exclusively for you and does not carry any right of publication or disclosure other than to Coöperatieve Rabobank U.A. (“Rabobank”), registered in Amsterdam. Neither this document nor any of its contents may be distributed, reproduced, or used for any other purpose without the prior written consent of Rabobank. Read more